We work to provide home health care you can trust.

For Investors

Amedisys, Inc. (NASDAQ: AMED) is a leading health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and their families, in the comfort of patients’ homes, with approximately 10 million patient care and education encounters per year. Amedisys has two divisions, home health care and hospice. The Company’s state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based u... More >>

Recent News

More >>
DateTitle 
Aug 2, 2016Amedisys Reports Second Quarter Financial Results
ANNOUNCES EXECUTIVE RETIREMENT TO HOST CONFERENCE CALL AUGUST 3, 2016 AT 11:00 A.M. ET BATON ROUGE, La., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2016. Three-Month Periods Ended June 30, 2016 and 2015  Net service revenue increased $46.6 million to $360.7 million compared to $314.1 million in 2015. Net income attributable to Am... 
Printer Friendly Version
Aug 1, 2016Amedisys Announces Definitive Agreement to Acquire Professional Profiles, Inc.
Deepens Strategic Commitment to Personal Care, Extends Care for Patients in the Home BATON ROUGE, La., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home health care and hospice companies, today announced that it has signed a definitive agreement to acquire Professional Profiles, Inc., a personal care company with corporate headquarters in Danvers, Massachusetts. Under the terms of the agreement, Amedisys will acquire substantially all of the asse... 
Printer Friendly Version
Jul 26, 2016Amedisys Announces Second Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., July 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America’s leading home health and hospice care companies, announced today that it will report results for the second quarter ended June 30, 2016 after the market closes on August 2, 2016.  The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on August 3, 2016. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-... 
Printer Friendly Version
Jun 17, 2016Amedisys Brings In David B. Pearce As New Chief Compliance Officer
BATON ROUGE, La., June 17, 2016 (GLOBE NEWSWIRE) -- David B. Pearce will join Amedisys, Inc. (NASDAQ:AMED), as Senior Vice President and Chief Compliance Officer, effective July 5. In his new role, Pearce will apply his expertise to manage and oversee the ethics and compliance programs at Amedisys. He will be responsible for developing and supervising policies, procedures and practices designed to promote ethical behavior and compliance with federal and state healthcare laws and regulations... 
Printer Friendly Version
DateTitle 
08/02/16Amedisys Reports Second Quarter Financial Results
ANNOUNCES EXECUTIVE RETIREMENT TO HOST CONFERENCE CALL AUGUST 3, 2016 AT 11:00 A.M. ET BATON ROUGE, La., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2016. Three-Month Periods Ended June 30, 2016 and 2015  Net service revenue increased $46.6 million to $360.7 million compared to $314.1 million in 2015. Net income attributable to Am... 
Printer Friendly Version
07/26/16Amedisys Announces Second Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., July 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America’s leading home health and hospice care companies, announced today that it will report results for the second quarter ended June 30, 2016 after the market closes on August 2, 2016.  The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on August 3, 2016. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-... 
Printer Friendly Version
05/03/16Amedisys Reports First Quarter Financial Results
Amedisys to Host Conference Call May 4, 2016 at 11:00 A.M. ET BATON ROUGE, La., May 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three-month period ended March 31, 2016. Three-Month Periods Ended March 31, 2016 and 2015 Net service revenue increased $47.2 million or 15.6% to $348.8 million compared to $301.6 million in 2015. Net income attributable to Amedisys, Inc. increased $41.... 
Printer Friendly Version
04/26/16Amedisys Announces First Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., April 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America’s leading home health and hospice care companies, announced today that it will report results for the first quarter ended March 31, 2016 after the market closes on May 3, 2016.  The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 4, 2016. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 ... 
Printer Friendly Version
There are currently no events scheduled.
Filing DateFormDescription
08/08/164Statement of changes in beneficial ownership of securities
IMPORTANT NOTICE TO USERS (summary only, click here for full text of notice): Certain financial and other information on the Investor Relations website is reproduced or derived from more comprehensive information contained in our quarterly earnings releases and periodic reports and other filings with the Securities and Exchange Commission. The information contained on the Investor Relations website is not intended as a substitute for, and should be read in the context of, the more comprehensive information contained in these other documents. In the event of any conflict, the information contained in our quarterly earnings releases and our periodic reports and filings with the SEC shall take precedence.